For the latter, elevated HbA2 levels of 10.7% (SD = 2.0%) potentially implicate a diagnosis of combined SUPT5H/HBB in beta-thalassemia carriers expressing beta-thalassemia intermedia. The gene discussed is SUPT5H; the disease is beta-thalassemia intermedia.